<DOC>
	<DOC>NCT00792337</DOC>
	<brief_summary>We hypothesize that simvastatin in combination with ICS might have synergistic anti-inflammatory effects on airway inflammation in asthmatic patients</brief_summary>
	<brief_title>The Additive Anti-inflammatory Effect of Simvastatin in Combination With Inhaled Corticosteroids in Asthma</brief_title>
	<detailed_description>To determine the additive effect of simvastatin on airway inflammation in ICS-treated patients with persistent asthma by measuring eosinophil counts in induced sputum</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>He or she has FEV1 &gt; 60% of predicted He or she requires less than 1000 mcg daily of beclomethasone or equivalent He or she had previous history of renal disease or serum creatinine more than 2 mg/dL He or she had previous history of liver disease She is pregnant or during lactation He or she has already received statins or is allergic to statins or has developed myositis. He or she has an asthma exacerbation and requires treatment with oral corticosteroids during the 3 months prior to the commencement of study entry.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>